Insider · CIK 0001506916

Meckler Jeffrey A

CIK 0001506916 Name as filed on the most recent filing

Filed as Meckler Jeffrey A (20)

24 transaction lines · from 20 filings · filed 2013-05-06 to 2026-05-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

24 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-04 S, Open-market sale Travere Therapeutics, Inc.TVTX 360,000, disposed Open Form 4 filing 0001506916-26-000001
2024-09-30 S, Open-market sale Travere Therapeutics, Inc.TVTX 562,324, disposed Open Form 4 filing 0001415889-24-024117
2022-11-21 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 18,240, acquired Open Form 4 filing 0001493152-22-033241
2022-11-18 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 705, acquired Open Form 4 filing 0001493152-22-033241
2022-09-08 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 28,862, acquired Open Form 4 filing 0001493152-22-025578
2022-09-07 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 22,184, acquired Open Form 4 filing 0001493152-22-025319
2022-09-06 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 2,586, acquired Open Form 4 filing 0001493152-22-025319
2022-06-06 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 51,882, acquired Open Form 4 filing 0001493152-22-016027
2021-11-18 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 65,108, acquired Open Form 4 filing 0001493152-21-029297
2021-09-14 P, Open-market purchase Indaptus Therapeutics, Inc.INDP 84,000, acquired Open Form 4 filing 0001493152-21-022936
2019-08-28 P, Open-market purchase Intec Pharma Ltd.NTEC 13,620, acquired Open Form 4 filing 0001213900-19-016939
2019-08-23 P, Open-market purchase Intec Pharma Ltd.NTEC 45,700, acquired Open Form 4 filing 0001213900-19-016791
2016-03-15 P, Open-market purchase Cocrystal Pharma, Inc.COCP 150,000, acquired Open Form 4 filing 0001415889-16-005138
2016-03-04 P, Open-market purchase Retrophin, Inc.RTRX 76,565, acquired Open Form 4 filing 0001209191-16-106796
2016-03-03 P, Open-market purchase Retrophin, Inc.RTRX 144,500, acquired Open Form 4 filing 0001209191-16-105744
2015-12-23 P, Open-market purchase Cocrystal Pharma, Inc.COCP 57,870, acquired Open Form 4 filing 0001415889-15-004182
2015-03-25 P, Open-market purchase Cocrystal Pharma, Inc.COCP 150,000, acquired Open Form 4 filing 0001415889-15-001063
2014-12-18 P, Open-market purchase QLT Inc/BCQLTI 72,000, acquired Open Form 4 filing 0001578259-14-000014
2014-12-11 P, Open-market purchase Cocrystal Pharma, Inc.COCP 3 lines 45,610, acquired Open Form 4 filing 0001415889-14-003885
2014-11-25 P, Open-market purchase Retrophin, Inc.RTRX 129,050, acquired Open Form 4 filing 0001209191-14-071141
2013-06-28 P, Open-market purchase QLT Inc/BCQLTI 130,800, acquired Open Form 4 filing 0001455244-13-000019
2013-05-03 P, Open-market purchase QLT Inc/BCQLTI 159,200, acquired Open Form 4 filing 0001455244-13-000004

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 22
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Meckler Jeffrey A, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001506916

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.